These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 31846247

  • 1. Psychosocial Implications of Tardive Dyskinesia in Patients With Mood Disorders Versus Schizophrenia.
    McEvoy JP.
    J Clin Psychiatry; 2019 Dec 03; 80(6):. PubMed ID: 31846247
    [Abstract] [Full Text] [Related]

  • 2. Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia.
    McEvoy J, Gandhi SK, Rizio AA, Maher S, Kosinski M, Bjorner JB, Carroll B.
    Qual Life Res; 2019 Dec 03; 28(12):3303-3312. PubMed ID: 31435866
    [Abstract] [Full Text] [Related]

  • 3. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS, Sauvanaud F, Limosin F.
    Encephale; 2016 Jun 03; 42(3):248-54. PubMed ID: 26922134
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
    Hauser RA, Factor SA, Marder SR, Knesevich MA, Ramirez PM, Jimenez R, Burke J, Liang GS, O'Brien CF.
    Am J Psychiatry; 2017 May 01; 174(5):476-484. PubMed ID: 28320223
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identifying Tardive Dyskinesia: Risk Factors, Functional Impact, and Diagnostic Tools.
    Saklad SR.
    J Clin Psychiatry; 2020 Jan 14; 81(1):. PubMed ID: 31944066
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The burden of tardive dyskinesia secondary to antipsychotic medication use among patients with mental disorders.
    McEvoy J, Park T, Schilling T, Terasawa E, Ayyagari R, Carroll B.
    Curr Med Res Opin; 2019 Jul 14; 35(7):1205-1214. PubMed ID: 30638073
    [Abstract] [Full Text] [Related]

  • 12. Subjective awareness of tardive dyskinesia and insight in schizophrenia.
    Emsley R, Niehaus DJ, Oosthuizen PP, Koen L, Chiliza B, Fincham D.
    Eur Psychiatry; 2011 Jul 14; 26(5):293-6. PubMed ID: 20615668
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical risk factors for the development of tardive dyskinesia.
    Solmi M, Pigato G, Kane JM, Correll CU.
    J Neurol Sci; 2018 Jun 15; 389():21-27. PubMed ID: 29439776
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.